SEC Form 4 · accession 0001628280-26-058256
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shannon T Kelley
Officer — General Counsel
Period of report
Aug 17, 2026
Accepted (ET)
Aug 20, 2026 · 4:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | S | 664 | $514.97 | D | 11,474 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.